A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Hematopoietic Stem Cell Transplant in Devic's Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Low-Grade Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate Safety and Efficacy of Caelyx in Combination With Cyclophosphamide in the Treatment of Metastatic Breast Cancer (P02948)
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Transplantation For Severe Osteopetrosis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL
- Status
- TERMINATED
- Phase
- NA
S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE3
Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Neoadjuvant in Inflammatory Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Anti-Cytokine Therapy for Vasculitis
- Status
- COMPLETED
- Phase
- PHASE2
Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides
- Status
- UNKNOWN
- Phase
- PHASE2